Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

U.S. Standards for ‘Safe’ Limits of PFCs in Drinking Water Appear too High for Children

Published: Wednesday, May 08, 2013
Last Updated: Wednesday, May 08, 2013
Bookmark and Share
A new environmental toxicity study has found that exposure limits for perfluorinated compounds (PFCs) found in drinking water appear to be 100 to 1,000 times too high.

PFCs are chemicals widely used in manufactured products such as non-stick cookware, waterproof clothing, and fast-food packaging.

Philippe Grandjean, adjunct professor of environmental health at HSPH, and Esben Budtz-Jørgensen of the University of Copenhagen, concluded that current exposure limits do not adequately protect children and other vulnerable groups against adverse effects on the human immune system. These same researchers showed in 2012 that routine childhood vaccines are less effective in children exposed to PFCs.

The new study, “Immunotoxicity of perfluorinated alkylates: Calculation of benchmark doses based on serum concentrations in children,” was published online April 18, 2013, in the BioMed Central open access journal Environmental Health.

The researchers compared blood concentration levels of PFCs for 431 five-year-olds in a birth cohort to serum antibody concentrations against tetanus and diphtheria toxoids in the same children at age 7. A doubling in PFC exposure was associated with a 50% decrease in the antibody concentration. As a threshold for this effect could not be identified, the researchers calculated a so-called benchmark dose to identify approximate exposure levels that would protect against the effect. The same method is used by EPA and other agencies.

“Most of the research on PFCs is fairly recent. So it’s no surprise that the EPA limits are already outdated. But if they are more 100 times too high, we need to discuss what went wrong and why the limits were so far off,” Grandjean said.

According to the authors, the discrepancy between the current safe levels and the tolerable exposure levels identified in the new study has occurred because PFCs have not been subjected to systematic toxicity testing, as they were ‘grandfathered’ in when the Toxic Substances Control Act (TSCA) was enacted in the U.S. in 1976. Although production of one of the compounds studied, PFOA (or C8), is currently being phased out in the U.S. and production of another (PFOS) has stopped, exposures continue due to the persistence of these compounds in the environment and in consumer products, and their continued production in other countries.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More Than 4,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Harvard Licenses Genotyping Platform
Novel approach aids development of drug resistance testing products for HIV.
Tuesday, May 24, 2016
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
Monday, May 23, 2016
New Weapon Against Breast Cancer
Molecular marker in healthy tissue can predict a woman’s risk of getting the disease, research says.
Thursday, April 07, 2016
Collaboration to Develop Cancer Therapeutics
Major license agreement with Merck, enabled by Blavatnik Biomedical Accelerator, aims to develop therapy for most common form of acute leukemia.
Tuesday, March 22, 2016
Scaling Up Tissue Engineering
Wyss Institute has invented Bioprinting technique that creates thick 3D tissues composed of human stem cells and embedded vasculature, with potential applications in drug testing and regenerative medicine.
Tuesday, March 15, 2016
Into Thin Air
Lower oxygen intake could be used to prevent mitochondrial diseases from forming.
Tuesday, March 01, 2016
High Poverty’s Effect on Childhood Leukemia
Patients more likely to suffer early relapses, which can be harder to treat.
Thursday, February 25, 2016
A Cancer’s Surprise Origins, Caught in Action
First demonstration of a melanoma arising from a single cell.
Monday, February 01, 2016
Seeing Hope
Gene therapy/drug combo restores some vision in mice with optic nerve injury.
Wednesday, January 20, 2016
Diagnosing Cancer from a Single Drop of Blood
What if a physician could effectively diagnose cancer from one drop of a patient’s blood?
Friday, January 08, 2016
Detecting When and Why Deadly Blood Clots Form
New bioinspired blood coagulation assay is more sensitive than existing assays and could one day be used to diagnose rare bleeding disorders and prevent toxic effects of anticoagulant and antiplatelet drugs.
Wednesday, January 06, 2016
Helping Cells Forget Who They Are
Erasing a cell’s memory makes it easier to manipulate them into becoming another type of cell.
Wednesday, December 23, 2015
Gut-on-a-Chip Model Offers Hope for IBD Sufferers
Wyss Institute replicates gut’s microenvironment in the lab, allowing researchers new access.
Thursday, December 17, 2015
Cell Memory Loss Enables the Production of Stem Cells
Scientists identify a molecular key that helps maintain identity and prevents the conversion of adult cells into iPS cells.
Thursday, December 17, 2015
Farming’s in Their DNA
Ancient genomes reveal natural selection in action.
Tuesday, November 24, 2015
Scientific News
Open Source Seed Initiative – A Welcome Boost to Global Crop Breeding
A team of plant breeders, farmers, non-profit agencies, seed advocates, and policymakers have created the Open Source Seed Initiative.
ASMS 2016: Targeting Mass Spectrometry Tools for the Masses
The expanding application range of MS in life sciences, food, energy, and health sciences research was highlighted at this year's ASMS meeting in San Antonio, Texas.
A New Way Out for Stem Cells
Researchers at North Carolina State University have discovered that therapeutic stem cells exit the bloodstream in a different manner than was previously thought.
One Giant Leap for the Future of Safe Drug Delivery
Sheffield engineers make major breakthrough in developing silk ‘micro-rockets’ that can be used safely in biological environments.
Designing Potential AIDS Vaccine Candidates
Findings represent ‘big accomplishment’ in biomedical engineering and design.
Anticancer Drug Stops Ebola Virus Molecule in its Tracks
A team of scientists from the University of Oxford have successfully mapped the structure of the Ebola virus molecule that drives the attack strategy and leads to fatal infections in humans.
Assessing the Effectiveness of Genome-Editing Technologies
Researchers have developed a cost-effective and rapid method for assessing edits generated by CRISPR-Cas9 and other genome-editing technologies.
Anthrax Proteins Might Help Treat Cancerous Tumors
Studies in mice reveal novel treatment regimen.
New Cancer Drug Target Found in Dual-Function Protein
Findings from a study from TSRI have shown that targeting a protein called GlyRS might help to halt cancer growth.
Key to Chronic Fatigue Syndrome is in Your Gut, Not Head
Researchers report they have identified biological markers of the disease in gut bacteria and inflammatory microbial agents in the blood.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!